A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
Temperatures will remain low for most of the country as Britain battles against wintry showers, snow and gales this afternoon.
A giant panda has been caught in camera breaking iron bars and moving into the other cell to have a taste of milk in the next cell.
City traders are paying up to £200 to cure their hangovers with a vitamin drip, according to a doctor from Surrey.